GlaxoSmithKline brands

“Horlicks is a terrific brand with a long history, especially in India,” said GSK Chief Executive Officer Emma Walmsley at an investors' meet last week. ... Though the prized catch would bring huge gains for the buyer — brands being reviewed amounted to sales of approximately £550 million in 2017, most of ...

Meanwhile, analysts see no lack of buyers for this legacy brand. “Packaged foods is an exciting space and GSK has strong brands which are likely to attract interest from potential buyers…We also believe the brands Horlicks and Boost have been under-leveraged,” brokerage firm CLSA said in a recent ...

Novartis sold its 37% share in consumer health concern, JV, for $13 billion. The Swiss company's stake is being bought by GlaxoSmithKline – Novartis' existing partner in the business. It will take 100% ownership of the unit, which boasts a slew of famous over-the-counter brands, such as Sensodyne and ...

Besides the Horlicks brand, GSK is exploring sale of its 72.5% stake in Indian subsidiary GSK Consumer Healthcare. “GSK needs the money to support the Novartis deal. Naturally, it would look to conclude the deal in foreign exchange. Global companies, with presence in both India and Malaysia, such as ...

The move is triggered by GSK's need to fund a $13 billion buyout of the remaining stake in its consumer healthcare joint venture with Novartis. The company is now ready to offload part of its consumer nutrition portfolio to sharpen the focus on its over-the-counter and oral healthcare brands such as ...

The stock price for Imperial Brands PLC EPIC code: LON:IMB has moved up 1.39% or 32.5 points during today's session so far. Market buyers have stayed positive throughout the trading session. The periods high has reached 2392.5 while the low for the session was 2329.5. Volume total for shares traded ...

GlaxoSmithKline (LSE:GSK) is Britain's biggest drugmaker. Last July the company said it would offload more than 130 of its non-core brands as it extended a restructuring programme meant to deliver £1bn in annual cost savings by 2020. In October, the chief executive, Emma Walmsley – who took over last ...

I'm always searching for shares that could offer good value for money in the Footsie, which is why I'm taking a closer look at the investment potential of Tesco PLC (LON:TSCO) (TSCO.L), Next plc (LON:NXT) (NXT.L), GlaxoSmithKline plc (LON:GSK) (GSK.L) and Imperial Brands PLC (LON:IMB) (IMB.L).

Valeant Pharmaceuticals Intl (NYSE: VRX) and GlaxoSmithKline (NYSE:GSK) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst ...

The Footsie continues to have investment appeal in my view, which is why I'm taking a closer look at the prospects for Tesco PLC (LON:TSCO) (TSCO.L), GlaxoSmithKline plc (LON:GSK) (GSK.L), HSBC Holdings plc (LON:HSBA) (HSBA.L), Imperial Brands PLC (LON:IMB) (IMB.L) and Prudential plc (LON:PRU) (PRU.L).

GlaxoSmithKline LLC was properly held liable for the suicide of a Chicago attorney who was taking a generic version of GSK's antidepressant Paxil, his ... Most courts that have considered this question have said a brand-name drug company can't be liable to a patient who used a generic drug, but there are ...

In addition, Imperial Brands has increasing exposure to the reduced risk product space. This may provide the company with the potential to generate rising sales and profit growth even if the trend away from smoking tobacco continues. Therefore, I feel that the company is well-placed to deliver high returns ...

GSK's Q3FY18 results were below our and consensus estimates. GSK revenue was flat, EBIDTA margin improved 1,270bps to 20.1% and net profit grew 156% YoY. GSK's major brands grew by high single digit to double digit during the quarter. That said, the company has a strong presence in the vaccines ...